William Lavery is a partner in the Antitrust and Competition Practice of Baker Botts' Washington, D.C. office. Some of the world's largest companies rely on Mr. Lavery's more than a decade of experience for major “bet the company” antitrust litigations, criminal and civil antitrust investigations, and mergers. Clients in industries including pharmaceutical, technology, foundry, chemical, energy, transportation and agriculture seek Mr. Lavery's representation in cases alleging a broad range of antitrust violations, including price-fixing, monopolization, Robinson-Patman violations, and sham litigation. Mr. Lavery also represents numerous companies in internal investigations and in implementing antitrust compliance programs.
Mr. Lavery was a member of the trial team that resulted in dismissals of six of the seven price-fixing and monopolization charges for McWane, Inc. in a recent eight-week bench trial against the FTC. The dismissals marked the first time in almost 20 years that the Commission ruled against itself following an in-house trial in front of the ALJ. The case earned the McWane trial team the award for “Behavioral Matter of the Year- Americas” by Global Competition Review in 2015.
Mr. Lavery's leadership roles include having served as the Chair of the Antitrust Law Committee for the ABA Young Lawyers Division for 2014-2015 and Vice-Chair of the Committee for 2013-2014. He is a sought-after writer and speaker on a wide range of antitrust topics, drafting dozens of articles and publications, including co-authoring a recent chapter of “GCR Know How,” as well as a chapter in a leading damages treatise. Mr. Lavery has been recognized for his work by Legal 500 U.S. (2017) and Super Lawyers (2014-2018), as well as being named a "Rising Star" by Law360 (2016), as one of the top competition lawyers under 40 in the country.